-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Raises Price Target to $810

Benzinga·10/08/2026 14:09:04
Listen to the news
RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and raises the price target from $737 to $810.